Allergan’s online promotional materials for its eyelash enhancer Latisse do not adequately show the potential risks of the product, according to the US Food and Drug Administration.
A US company's eyelash lengthening product is currently under
investigation by the Medicines and Healthcare products Regulatory
Agency (MHRA) in the UK following its removal from the US market.
Regulators seized about $2m worth of an eyelash lengthening
product, one of a new breed of beauty goods that fall into
regulatory no-man's land between drugs and cosmetics.
